DR. DIANA ROSE GREEN O.D.
Prescription History 1982992145
Optometrist in Brighton, MA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. DIANA ROSE GREEN O.D., an active Optometrist specialist practicing in Brighton, MA. Our medical registry currently tracks 8 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 260 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 95 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other MA PrescribersVs. MA Avg |
|---|---|---|---|
| Latanoprost | 95 | $9.02▼ below MA avg | ▼ Less than typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2024, this provider wrote 95 Medicare prescriptions for Latanoprost, about half the volume of the typical Massachusetts prescriber of this medication (169.8). Medicare paid an average of $9.02 per fill, versus $13.23 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 165 30-Day Fills standardized to 30-day supplies 4,732 Days of Medication total across all patients in 2024 | |||
| RestasisCyclosporine | 40 | $1,124.86 | ≈ Typical |
About Restasis: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed). In 2024, this provider wrote 40 Medicare prescriptions for Restasis, about 88% of the volume of the typical Massachusetts prescriber of this medication (45.5). Medicare paid an average of $1,124.86 per fill, versus $1,033.90 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 71 30-Day Fills standardized to 30-day supplies 2,115 Days of Medication total across all patients in 2024 | |||
| Brimonidine Tartrate | 29 | $90.85 | ▼ Less than typical |
About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2024, this provider wrote 29 Medicare prescriptions for Brimonidine Tartrate, about a third of the volume of the typical Massachusetts prescriber of this medication (89.5). Medicare paid an average of $90.85 per fill, versus $42.13 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 60.1 30-Day Fills standardized to 30-day supplies 1,710 Days of Medication total across all patients in 2024 | |||
| Cyclosporine | 27 | $510.39 | ≈ Typical |
About Cyclosporine: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed). In 2024, this provider wrote 27 Medicare prescriptions for Cyclosporine, about 86% of the volume of the typical Massachusetts prescriber of this medication (31.4). Medicare paid an average of $510.39 per fill, versus $398.97 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 53 30-Day Fills standardized to 30-day supplies 1,575 Days of Medication total across all patients in 2024 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 20 | $8.53▼ below MA avg | ▼ Less than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2024, this provider wrote 20 Medicare prescriptions for Dorzolamide-Timolol, about a quarter of the volume of the typical Massachusetts prescriber of this medication (95.6). Medicare paid an average of $8.53 per fill, versus $19.13 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 28.3 30-Day Fills standardized to 30-day supplies 849 Days of Medication total across all patients in 2024 | |||
| Timolol Maleate | 19 | $16.85▼ below MA avg | ▼ Less than typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2024, this provider wrote 19 Medicare prescriptions for Timolol Maleate, about 18% of the volume of the typical Massachusetts prescriber of this medication (106.6). Medicare paid an average of $16.85 per fill, versus $24.95 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 29.5 30-Day Fills standardized to 30-day supplies 884 Days of Medication total across all patients in 2024 | |||
| Dorzolamide-TimololDorzolamide/Timolol/Pf | 16 | $127.85▼ below MA avg | ▼ Less than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2024, this provider wrote 16 Medicare prescriptions for Dorzolamide-Timolol, about half the volume of the typical Massachusetts prescriber of this medication (33). Medicare paid an average of $127.85 per fill, versus $168.28 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 20 30-Day Fills standardized to 30-day supplies 600 Days of Medication total across all patients in 2024 | |||
| XiidraLifitegrast | 14 | $1,218.00 | ▼ Less than typical |
About Xiidra: This medication is used to treat dry eye disease. Show more ▾ An LFA-1 (LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1) antagonist that is used in the treatment of DRY EYE SYNDROMES. In 2024, this provider wrote 14 Medicare prescriptions for Xiidra, about half the volume of the typical Massachusetts prescriber of this medication (28.2). Medicare paid an average of $1,218.00 per fill, versus $1,106.82 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 26 30-Day Fills standardized to 30-day supplies 780 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for DR. DIANA ROSE GREEN O.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Optometrist prescribing approach at this Brighton, MA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among MA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
